PTC Therapeutics, Inc. (PTCT) Stock Total Returns
Growth of $10,000 chart
2021-04-12 to 2026-04-10 to
$
%
%
Loading chart…
Investment Performance
Final Value
$14,575
Total Return
45.75%
CAGR
7.83%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.97% |
| Median | +1.65% |
| Best | +71.41% |
| Worst | -49.03% |
| % of Windows Positive | 54.1% |
1-Year (252 Trading Days)
| Average | +20.28% |
| Median | +20.97% |
| Best | +140.67% |
| Worst | -60.92% |
| % of Windows Positive | 61.1% |
3-Year (756 Trading Days)
| Average | +24.31% |
| Median | +16.49% |
| Best | +117.62% |
| Worst | -48.77% |
| % of Windows Positive | 71.1% |
Risk Metrics
| Maximum Drawdown | -69.42% |
| Average Drawdown | -24.80% |
| Drawdown Duration | 577 Trading Days |
| Sortino Ratio | 0.61 |
| Calmar Ratio | 0.11 |
| CVaR (5%) | -7.38% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -9.57% (-30.75% ann.) | $957.08 | $0.00 | $0.00 | $0.00 |
| 2025 | +68.28% | +$6827.64 | $0.00 | $0.00 | $0.00 |
| 2024 | +63.79% | +$6378.81 | $0.00 | $0.00 | $0.00 |
| 2023 | -27.80% | $2779.67 | $0.00 | $0.00 | $0.00 |
| 2022 | -4.17% | $416.77 | $0.00 | $0.00 | $0.00 |
| 2021 | -34.74% | $3473.70 | $0.00 | $0.00 | $0.00 |
| 2020 | +27.07% | +$2706.64 | $0.00 | $0.00 | $0.00 |
| 2019 | +39.95% | +$3994.76 | $0.00 | $0.00 | $0.00 |
| 2018 | +105.76% | +$10575.54 | $0.00 | $0.00 | $0.00 |
| 2017 | +52.89% | +$5288.73 | $0.00 | $0.00 | $0.00 |
| 2016 | -66.33% | $6632.72 | $0.00 | $0.00 | $0.00 |
| 2015 | -37.42% | $3741.55 | $0.00 | $0.00 | $0.00 |
| 2014 | +205.07% | +$20506.77 | $0.00 | $0.00 | $0.00 |
| 2013 partial | +2.91% (+5.55% ann.) | +$291.09 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 20, 2013 – February 19, 2020 | +259.98% | +21.18% | +$25997.58 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -28.88% | -97.95% | $2887.53 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +39.62% | +71.09% | +$3961.91 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -37.70% | -36.17% | $3769.63 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -5.06% | -5.36% | $505.92 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -7.83% | -4.30% | $783.18 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 10, 2026 | +93.60% | +52.82% | +$9360.20 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.